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To investigate the relation between basal coronary artery 
diameter and development of coronary artery spasm, the 
diameters of the proximal, middle and distal segments of 
the three major coronary artery branches, together with 
that of the left main trunk, were measured on a control 
angiogram and after ergonovine and nitrate administration 
in 30 patients with vasospastic angina without significant 
organic stenosis, and in 35 patients without ischemic heart 
disease. The percent change in coronary diameter after 
ergonovine and nitrate administration compared with the 
control diameter was used as an index of coronary vasore- 
activity. 
In patients with vasospastic angina, coronary artery 
responses to both ergonovine and nitrate were greater in 
the spastic segments than in the other segments (p < 0.05), 
and those of the coronary arteries without spasm were 
greater than those of the coronary arteries in patients 
without ischemic heart disease (p < 0.01). There were no 
significant differences between the coronary artery diame- 
ters in the two groups after nitrate administration, and the 
control diameters were less in patients with vasospastic 
angina than in patients without ischemic heart disease. 
These observations indicate that a coronary vasomotion 
disorder, which involves increased basal coronary artery 
tone and hypersensitivity to vasoconstrictive stimuli, not 
only at a localized segment but also in the entire coronary 
artery tree, is present in patients with vasospastic angina. 
Clinically, evaluation of basal coronary artery tone may he 
useful for predicting the occurrence and location of coro- 
nary artery spasm. 
(.I Am Co11 Cardiol1989;14:6049) 
It is well known that coronary artery spasm is a cause of 
ischemia in patients with rest angina; however, the causes of 
coronary spasm are still unknown. An early report (I I 
suggested that significant coronary obstruction could be due 
to normal vasomotion in the coronary arteries with organic 
stenosis. However. other investigators (2-5) reported that a 
localized disorder in coronary vasoreactivity is present in 
patients with coronary spasm. 
On the basis of the observation that coronary artery 
spasm tends to recur in the same coronary segments (3,6) 
and that the coronary vasodilation produced by nitrate 
administration in patients with variant angina is greater than 
that in patients without variant angina (5). we presumed that 
local hypersensitivity to vasoconstrictive stimuli and in- 
creased basal coronary artery tone might play a major role in 
the genesis of coronary artery spasm. In addition, several 
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reports (7-9) have indicated the similarity of spontaneous 
and ergonovine-induced attacks of coronary spasm. 
The purpose of this study was to quantify coronary artery 
responses to ergonovine and nitrate in patients without 
significant organic stenosis, and to investigate the signifi- 
cance of coronary artery tone in patients with vasospastic 
angina. 
Methods 
Patient selection. A retrospective analysis was per- 
formed, involving 159 patients who had undergone diagnos- 
tic coronary angiography with the ergonovine provocative 
test and who had normal coronary arteries or fixed lesions 
with ~40% diameter reduction after nitrate administration. 
Sixty-five of these patients were separated into two groups 
according to the clinical findings and the results of the 
ergonovine provocative test. None of the patients had prior 
myocardial infarction. Informed consent was obtained from 
each patient. 
T/P wso.spnstic ctngina group consisted of 30 patients 
(average age 57 years, range 42 to 73) with suspected variant 
angina and coronary artery spasm during the ergonovine 
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provocative test. All patients had chest pain at rest. which 
was relieved by sublingual nitrate. 
The normgina group consisted of 35 patients (average 
age 49 years, range 32 to 67) without chest pain or ischemic 
heart disease. Ten patients had hypertrophic cardiomyopa- 
thy, 10 had valvular heart disease, 7 had arrhythmia. 4 had 
electrocardiographic (ECG) ST-T changes without chest 
pain, 3 had a coronary artery fistula and I had an atrial septal 
defect. 
Catheterization procedure. Coronary angiography was 
performed with the Sones technique. Pharmacologic therapy 
was withheld for at least 24 h before cardiac catheterization. 
After coronary angiography was performed without premed- 
ication as a control, ergonovine (0.05 to 0.20 mg) was 
administered as a bolus injection into the ascending aorta. 
Heart rate, intraaortic blood pressure and ECG lead II were 
continuously monitored, and standard 12 lead ECGs were 
recorded at 30 s intervals. Coronary angiography was per- 
formed immediately if typical chest pain or ECG changes 
indicating myocardial ischemia occurred. In the absence of 
these symptoms after ergonovine administration. coronary 
angiography was performed 4 min later. Additional er- 
gonovine (0.05 to 0.2 mg) was administered to patients who 
did not develop coronary artery spasm after the initial dose 
of ergonovinc. The same angiographic procedure was then 
repeated. Either nitroglycerin (0.33 mg) or isosorbide dini- 
trate (5 mg) was administered as a bolus injection into the 
ascending aorta after both coronary arteries were visualized. 
Coronary angiography was repeated 2 to 4 min after nitrate 
administration. 
Analysis of coronary angiograms. The 35 mm coronary 
angiograms were reviewed on a Vanguard projector. Coro- 
nary artery diameter was measured in the proximal, middle 
and distal segments of the three major coronary artery 
branches. together with that of the left main trunk and in the 
spastic segments in which coronary artery spasm was pro- 
voked by ergonovine. Right coronary artery diameter was 
measured distal to the sinus node artery (proximal), distal to 
the right ventricular branch (middle) and distal to the acute 
marginal branch (distal). The left main trunk diameter was 
measured just before the artery’s bifurcation. The left ante- 
rior descending coronary artery diameter was measured at 
the artery’s origin (proximal). distal to the first septal perfo- 
rator (middle) and distal to the second septal perforator 
(distal). The left circumflex artery diameter was measured at 
the artery’s origin (proximal), distal to the obtuse marginal 
branch (middle) and at the origin of the posterior lateral 
branch (distal). When the spastic segment was at the same 
site as I of the IO divided nonspastic segments. the segment 
was excluded from the measurement of the nonspastic 
segment. In addition, when the spastic segment had a 
diameter reduction >90% after ergonovine administration. 
made near the center of the angiograms. Serial measure- 
ments were taken at end-diastole in the 30” right anterior 
oblique projection of the left coronary artery and the 60” left 
anterior oblique projection of the right coronary artery. The 
coronary artery diameter (in millimeters) was calculated 
with reference to the Sones catheter tip diameter (I .7 mm). 
The reproducibility of these measurements was good, with 
an intraobserver correlation of r = 0.93 and an interobserver 
correlation of r = 0.93 for 1 I I coronary artery segments. The 
error in duplicate measurements of the diameter of the 
proximal anterior descending segment obtained with this 
technique was 0.5 mm (twice the standard deviation of the 
difference between the first and second measurements, n = 
50 duplicate measurements). The percent vasoconstriction 
by ergonovine and vasodilation by nitrate were used to 
quantify the degree of coronary artery tone. 
The percent change in coronary artery diameter IVNS 
cul~~lrl~lted NS follon’s: 
Percent vasoconstriction by ergonovine = 
Control diameter - Diameter after ergonovine x ,oo ,~,. - c 
Control diameter 
Percent vacodilation by nitrate = 
Diameter after nitrate - Control diameter 
- x 100 (rc). 
Control diameter 
Both control diameters used in these two equations were 
measured on the control angiogram. Dynamic coronary 
diameter reduction >50% from the control diameter (focal or 
diffuse) was considered to represent coronary artery spasm 
(IO). 
Statistics. The mean values from control angiograms and 
after ergonovine and nitrate administration were compared 
with the paired t test. The unpaired t test was used to 
compare the mean values of a single variable between the 
vasospastic angina and nonangina groups. A probability (p) 
value CO.05 was considered to be statistically significant. All 
grouped data were reported as mean values -+ standard 
error. 
Results 
Nonangina group. The mean dose of ergonovine in these 
3S patients was 0.22 t 0.013 mg. and no patient had 
coronary artery spasm or transient ST segment shifts during 
the ergonovine provocative test. 
Vasospastic angina group. The mean dose of ergonovine 
in these 30 patients was 0.17 2 0.018 mg, which was 
significantly less than that in the nonangina group (p < 0.05). 
With ergonovine administration, 25 patients had spasm in 
one major coronary artery, and 5 had spasm in two major 
coronary arteries simultaneously. Spasm was observed in 
the distal segments of the vessel were excluded in this study. the right coronary artery in 22 patients. the left anterior 
To minimize pincushion distortion. measurements were descending coronary artery in IO patients and the left cir- 
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Table 1. Coronary Artery Diameter on the Control Angiogram and After Nitrate Administration in 65 Patients 
Control Angiogram After Nitrate 
Nonangina VSA Nonangina VSA 
(n = 35) (n = 30) (n = 35) (n = 30) 
RCA 
Proximal 3.15 + 0.12 2.55 2 0.1s: 3.75 ? 0.14 3.76 2 0.16 
Middle 2.88 2 0.11 2.40 ? 0.14* 3.45 + 0.14 3.74 + 0.14 
Distal 2.67 2 0.11 2.36 ? 0.13 3.27 * 0.14 3.51 f 0.14 
LAD 
Proximal 3.40 5 0. IO 2.58 2 O.lli 3.74 * 0.1 I 3.59 + 0.15 
Middle 2.27 ? 0.08 1.74 i 0.09+ 2.61 ? 0.09 2.57 f 0.10 
Distal 1.75 2 0.06 I .36 = 0.06+ 2.00 + 0.07 1.91 ? 0.07 
LCX 
Proximal 2.84 2 0.08 2.40 2 0.14: 3.32 ? 0.10 3.22 ? 0.12 
Middle 2.62 5 0.12 1.92 2 0.13: 2.91 2 0.13 2.65 z 0.16 
Distal 2.00 f 0.10 1.37 * 0.07: 2.31 * 0.10 2.01 -c 0.11 
LMT 4.16 2 0.12 3.59 + O.lli 4.43 f 0.14 4.28 t 0.12 
*p < 0.05, tp < 0.01 compared with the nonangina group. Values are reported as mean ? standard error. 
LAD = left anterior descending artery; LCx = lefl circumflex artery: LMT = left mam trunk; RCA = right coronary artery; VSA = vaaospastic angina. 
cumflex coronary artery in 3 patients; it was not observed in 
the left main trunk. Thirteen (43%) of the 30 patients with 
vasospastic angina had transient ST segment elevation with 
chest pain after ergonovine administration. Because nitro- 
glycerin (17 patients in the nonangina group and 8 in the 
angina group) and isosorbide dinitrate (18 patients in the 
nonangina and 22 in the angina group) produced similar 
absolute and percent increases in coronary diameter in the 
nonangina and vasospastic angina groups, the results with 
the two drugs were pooled for analysis. 
Effect of nitrate on diameter in each major coronary artery 
(Tables 1 and 2). Excluding the spastic segments, the con- 
trol diameters of all but the right distal segment were smaller 
in the vasospastic angina group than in the nonangina group 
(p < 0.05) (Table I). The control diameter of the right distal 
segment showed a tendency to be smaller in the vasospastic 
angina group than in the nonangina group (p < 0.10). The 
Table 2. Percent Vasodilation After Nitrate Administration in 
Proximal, Middle and Distal Segments in 65 Patients 
% Vasodilatlon by Nitrate 
Proximal Middle Distal 
Nonangina (n = 35) 
RCA 
LAD 
LCX 
VSA (n = 30) 
RCA 
LAD 
LCX 
20 2 3 20 + 2 23 2 3 
10 * 2 16? 3 IS ? 3 
I7 t 2 I! ? 2 I7 2 3 
51 ?6 63 ? 8 52 ? 4 
41 +4 51 +6 43 ? 5 
39 ? 4 42 ? 4 49 ? 5 
Values are reported as mean 2 standard error. Abbreviations as in 
Table I. 
coronary artery diameters of all segments after nitrate ad- 
ministration were similar in the two groups (p = NS). 
The percent vasodilation after nitrate administration was 
similar in all segments in each major coronary artery branch 
(p = NS) (Table 21. Because the percent vasodilation by 
nitrate was not related to location (proximal, middle and 
distal segments) in each of the three major coronary artery 
branches, results in the three segments in each major coro- 
nary artery branch were combined for subsequent analysis. 
Comparison of group responses to nitrate (Fig. 1). Exclud- 
ing the spastic segments, the percent vasodilation after 
administration of nitrate of the right, left anterior descending 
and circumflex coronary arteries, together with that of the 
left main trunk, was 21 2 1%. 14 2 2%, 15 ? 1% and 7 f I%, 
respectively. in the nonanginagroup, and 56 ? 4%, 45 +- 3%. 
43 * 3% and 20 2 3%, respectively, in the vasospastic 
angina group. In both groups, the percent vasodilation of the 
left main trunk was less than that of the other three major 
coronary artery branches (p < 0.01). and the percent vaso- 
dilation of the right coronary artery was greater than that of 
the left anterior descending (p < 0.05) and circumflex 
coronary arteries (p < O.Ol), whereas that of the left anterior 
descending and circumflex coronary arteries was similar 
(p = NS). The responses to nitrate in the three major 
coronary artery branches (p < 0.01) and left main trunk (p < 
0.05) were all greater in the vasospastic angina group than in 
the nonangina group. 
Effects of ergonovine and nitrate on diameter of the spastic 
and nonspastic segments (Fig. 2). The percent vasoconstric- 
tion after administration of ergonovine in the spastic seg- 
ments, adjacent segments and segments of the coronary 
arteries without spasm in the vasospastic angina group and 
the combined segments in the nonangina group was 
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Figure 1. Coronary artery response to nitrate shown as the percent 
vasodilation by nitrate. Excluding the spastic segments, the percent 
vasodilation by nitrate was compared among the three major coro- 
nary artery branches together with the main trunk, and between the 
nonangina (open bars) and vasospastic angina (WA) (hatched bars) 
groups. *p < 0.05; **p < 0.01. LAD = left anterior descending 
coronary artery; LCX = left circumflex coronary artery: LMT = left 
main trunk: NS = not significant: RCA = right coronary artery. 
76 ? 3%, 24 t 2%, 13 t 1% and 8 2 I%, respectively. 
Percent vasodilation after nitrate administration in those 
segments was 64 ? 5%. 51 i 3%. 42 5 2% and 16 ? I%, 
respectively. The coronary artery responses to ergonovine 
and nitrate were greater in the spastic segments than in the 
adjacent segments and segments of the coronary arteries 
without spasm (p < 0.05). The responses in the nonangina 
group were less than those in the segments of the coronary 
arteries without spasm (p < O.OI), which were less than 
those in the adjacent segments (p < 0.05). 
Discussion 
Previously, coronary vasomotion disorder in response to 
ergonovine or nitrate in patients with vasospastic angina has 
been documented with quantitative angiographic techniques. 
Previous studies (2,4) using ergonovine distinguished be- 
tween the segments with and without spasm. In contrast, a 
study (I 1) using nitrate did not show data relative to seg- 
ments with and without spasm. In other studies the number 
of patients was small (6) or the location of coronary artery 
spasm was unclear (5). Furthermore, there were few studies 
that dealt with differential coronary responses to ergonovine 
and nitrate in patients with vasospastic angina compared 
with the control patients. Therefore, using quantitative cor- 
onary angiography, we investigated in detail responses to 
ergonovine and nitrate in patients with vasospastic angina 
and compared them with responses in control patients. 
In describing variant angina in 1959. Prinzmetal et al. (12) 
suspected that the disease resulted from temporary occlu- 
sion of a coronary artery with significant organic stenosis 
due to a normal increase in coronary artery tone. Similarly, 
MacAlpin (1) suggested that significant coronary obstruc- 
tion, even complete occlusion, could be dynamically pro- 
duced by physiologic degrees of vasoconstriction at the site 
of the stenosis. Therefore, we selected patients without 
significant organic stenosis to rule out the possibility that 
coronary artery spasm could be a result of normal vasomo- 
tion in the coronary arteries with significant organic stenosis. 
Coronary vasomotion disorder in response to ergonovine in 
vasospastic angina. Although ergonovine produces mild dif- 
fuse coronary vasoconstriction in patients with atypical 
chest pain (8,13-16) or a transplanted heart (141, a localized 
disorder in which the spastic segments in patients with 
spasm shows greater sensitivity to a vasoconstrictor than 
other segments has been suggested as a mechanism of 
coronary artery spasm (2-4). Similarly, our data show that 
the spastic segments were more sensitive to ergonovine than 
were the nonspastic segments of the patient with vasospastic 
angina and the coronary arteries of the control patients. 
However, excluding the spastic segments, coronary artery 
responses to ergonovine were greater in the vasospastic 
angina group than in the nonangina group; even coronary 
arteries without spasm in these patients showed greater 
sensitivity to ergonovine than did the coronary arteries of 
the control patients. Consequently. coronary arteries of 
patients with vasospastic angina are hypersensitive to er- 
gonovine, not only in the spastic segments, but also in 
arteries without spasm. 
Coronary vasomotion disorder in response to nitrate in 
vasospastic angina. Like the ergonovine response (Fig. Z), 
coronary vasodilation after nitrate appears much more 
prominent in spastic segments than in other segments, and in 
coronary arteries without spasm than in the coronary arter- 
ies of control patients. The actual control baseline diameter 
measurements were significantly smaller in patients with 
vasospastic angina than in the control patients, excluding the 
spastic segments. However, the diameter measurements 
after nitrate administration were similar in both groups. 
Thus, in contrast to observations by Hill et al. (5), who 
suggested that a localized disorder in coronary vasodilation 
after nitroglycerin is present in patients with spasm, our 
findings suggest that the entire coronary artery tree rather 
than a localized segment may have increased basal coronary 
tone and may exhibit a smaller control diameter and in- 
creased basal coronary tone and sensitivity to vasoconstric- 
tive stimuli. 
This finding may explain the following observations. 
Coronary artery spasm may not be in the same location 
during every angina1 attack, may involve an entire coronary 
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Figure 2. Percent vasoconstriction after ergonovine (left i and vaso- 
dilation after nitrate (right) compared among the spastic segments. 
adjacent segments and segments of the coronary arteries without 
spasm in the vasospastic angina group and the combined segments 
in the nonangina group. *p < 0.0s; **p < 0.01. 
artery diffusely, even into smaller branches without focal 
vasoconstriction (17) and may occur in multiple segments in 
a “migratory fashion” from one artery to another or from 
one site to another within one artery (IS). Spontaneous 
coronary artery spasm during coronary angiography has 
been documented (I9-21), and is probably more common 
than generally recognized (22,23). 
According to Epstein and Talbot (24), mild to moderate 
increased coronary artery tone could predispose to coronary 
spasm. Ross et al. (25) speculated that an alteration in 
activational mechanisms from tonic to phasic might play a 
role in spasm. Furthermore, Yasue et al. (II) showed that 
the percent vasodilation after nitroglycerin was significantly 
higher in the early morning than in the afternoon, and this 
observation was interpreted as showing increased basal 
coronary artery tone in the morning in patients with variant 
angina. 
Different coronary responses to nitrate in the three major 
coronary artery branches and left main trunk. Several inves- 
tigators (26-28) observed that during coronary angiography. 
the smaller the control diameter. the greater the coronary 
vasodilation after nitrate administration. The reason for this 
observation may be increased basal coronary artery tone, 
which is reflected by a smaller control diameter. Some 
patients with chest pain syndrome selected by those inves- 
tigators may have had vasospastic angina, as evidenced by 
the fact that the frequency of provoked coronary artery 
spasm during coronary angiography was only 38% in pa- 
tients with rest angina (29). Simonetti et al. (28). examining 
responses to isosorbide dinitrate, suggested that the reason 
for these different responses in arteries of varying sizes may 
be increased basal coronary artery tone or hypersensitivity 
to coronary vasodilators, or both, of small compared with 
large coronary arteries. Our data show that coronary artery 
responses to nitrate are not related to location in each major 
coronary artery branch, and indicate that, clinically, coro- 
nary artery diameter after nitrate administration should be 
regarded as a standard diameter for making comparisons 
between patients with vasospastic angina and control pa- 
tients. 
Coronary cwtety responses to nitrate were greater in the 
right coroncrry artery than in the other arteries; specifically. 
basal coronary artery tone was higher in the former than in 
the latter. This finding may support our observation that the 
right coronary artery is more prone to spasm than the other 
arteries, although coronary artery response to ergonovine in 
the former was similar to that in the latter. Similarly, Higgins 
et al. (19) reported that most cases of documented coronary 
artery spasm involved the right coronary artery, and ST 
segment elevation was observed most often in the inferior 
ECG leads in patients with variant angina and “normal” 
coronary arteries. A similar distribution was found in several 
other reports (29-31). Chahine et al. (22) suggested that it 
may be caused by a difference in innervation. 
Clinical implications. The ergonovine provocative test is 
highly sensitive and specific for the detection of coronary 
artery spasm @,9,13-16), but some risks to its use do exist 
(8,15,16,32). If coronary artery spasm could be identified 
without the provocative test, prediction of vasospastic an- 
gina would be safer. When patients have not taken nitrate, 
the initial coronary angiograrns will presumably reflect the 
basal state of coronary artery tone (5). Evaluation of basal 
coronary artery tone may be useful for predicting the occur- 
rcnce and location of coronary artery spsam in patients who 
have not been previously recommended for the provocative 
test of spasm, such as with coronary spasm in significant 
organic stenosis. 
We are very grateful to Hiroyuki Miyakoda. MD and Junichi Hasegawa, MD 
for their constructive criticism. 
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